Core Viewpoint - Haisong Medical (06078) issued a profit warning, expecting a significant decline in mid-term net profit by approximately 34% to 39% year-on-year, leading to a drop of over 5% in stock price [1] Financial Performance Summary - For the six months ending June 30, 2025, the company anticipates a revenue decrease of about 15% to 17% compared to the same period last year [1] - The expected net profit decline is projected to be around 34% to 39% year-on-year [1] - Adjusted net profit, according to non-International Financial Reporting Standards, is expected to decrease by approximately 32% to 37% compared to the previous year [1] - Operating cash flow is expected to improve by about 28% to 32% year-on-year [1] Industry Impact Summary - The decline in revenue and profit is primarily attributed to industry factors such as centralized procurement, DRG payment reforms, and macroeconomic influences [1] - The increase in depreciation and amortization from newly opened hospitals also contributed to the financial downturn [1]
港股异动 | 海吉亚医疗(06078)盈警后跌超5% 预计中期净利润同比下降约34%至39%